Vidence powers
a cancer-free future

Enabling the development of new treatments for patients through data-driven, evidence-based analytics and insights.

Vidence harnesses the power of clinical and genomic data and insights to advance the treatment and outcomes for oncology patients.

A healthcare informatics company, we provide the world’s leading cancer researchers, innovators and treatment providers with the ability to contribute to and access the most comprehensive knowledge base of patient journeys and outcomes.

Value & Quality

Our oncology data, services, and technology are unparalleled in the industry

100,000+

Patient journeys and growing through the Consortium

50,000+

Patient reported outcomes

12,000+

Patients with detailed 
genomic sequencing

Our Roots

Vidence originated from the founders of the renowned Cancer Treatment Centers of America (CTCA), a network of hospitals across the U.S. dedicated to personalized, integrated medicine in the treatment of cancer patients for more than 30 years.

In 2019, we established Vidence as an independent company in order to expand the impact of data-driven analytics and data stewardship in oncology to a broader network, merging deep roots and a proven track record in healthcare, oncology, and data and analytics.